Objectives-Transcranial Doppler ultrasound is used to identify patients with sickle cell disease (SCD) at risk for stroke. We performed transcranial Doppler studies in patients from 4 countries in the Arabian Peninsula (Kuwait, Oman, Iraq, and United Arab Emirates) to document the prevalence of abnormal transcranial Doppler findings.
A lthough sickle cell disease (SCD) is a monogenic disease caused by the inheritance of the abnormal sickle hemoglobin (Hb), the disease is highly variable with different genetic and environmental factors modulating its phenotype. Among the former are the b S -globin gene haplotype, fetal hemoglobin (HbF) level, and coexistent a-thalassemia trait. [1] [2] [3] [4] [5] However, there are several other genetic polymorphisms in different signaling or inflammatory pathways that are increasingly being shown to play modifying roles. 6 The most debilitating complication of SCD is stroke, which is usually ischemic in childhood and hemorrhagic in adults. It also tends to be recurrent and can be fatal or leave severe neurologic sequelae.
For this reason, patients are screened with transcranial Doppler ultrasound to identify those at risk, in whom chronic transfusion therapy is recommended for primary or secondary prevention of stroke. 8, 9 The usual site of stenosis is in the large arteries of the circle of Willis, especially the anterior circulation: ie, terminal internal carotid artery (ICA), anterior cerebral artery (ACA), and middle cerebral artery (MCA). In transcranial Doppler ultrasound, the time-averaged maximum mean velocity (TAMMV) in each of these arteries is recorded, and a value of greater than 200 cm/s is considered abnormal (ie, at risk for stroke), whereas values between 170 and 200 cm/s are conditional, and those of less than 170 are normal. 8, 9 Table 1 shows reported transcranial Doppler values from the United States, 10, 11 France, 12 Brazil, 13, 14 Tanzania, 15 Nigeria, [16] [17] [18] and Iran 19 in which the proportions with abnormal values ranged from 1.6% to 20.7%. However, the 2 studies from the Arabian Peninsula (Oman and Kuwait) did not record any abnormal values, 20, 21 whereas the study from Iran reported 3%. 19 The question therefore arises of whether the results from these countries could be reproduced among other Peninsular Arabs, and whether this variation is related to the b S haplotypes, HbF level, and hydroxyurea therapy or race/ethnicity.
Most patients with SCD in Kuwait carry the ArabIndia (AI) haplotype and have uniformly elevated HbF levels. 22, 23 Many SCD complications such as stroke, priapism, chronic leg ulcers, and silent brain infarcts are rare in pediatric patients. Patients with SCD in Iraq show more variety in their haplotype backgrounds, with Benin (BEN) being more predominant among Kurdish patients in the northern part 24 but AI in southern Arab patients. Oman is unique in the Arabian Peninsula; the BEN, AI, and Bantu (BAN) haplotypes are encountered frequently because of their geopolitical history and early migrations/interactions. 25 Most patients with SCD in the United Arab Emirates also carry the AI haplotype, although both the BEN and BAN are also encountered with less frequencies. 26 In this study, we sought to test the hypothesis that abnormal transcranial Doppler findings are rare in Peninsular Arabs. We compared transcranial Doppler data from patients with SCD in Kuwait to those from Muscat in Oman, Al Ain in the United Arab Emirates, and Basra in southern Iraq. We also investigated the relationship between the values and selected clinical, hematologic, and laboratory parameters.
Materials and Methods
This report is an analysis of pooled data generated from independent cross-sectional prospective studies conducted in the Arabian Peninsula within the last 3 years. The study patients were consecutive patients seen in the Pediatric Hematology Clinics of Al-Amiri and Mubarak Al-Kabeer Hospitals in Kuwait, Royal Hospital in Muscat, Oman, Center for Hereditary Blood Diseases, Basra Maternity and Children Hospital in Basra, Iraq, and Tawam Hospital in Al Ain, United Arab Emirates. Although the Kuwaiti patients were part of a previous study, 21 the patients from the other 3 countries had not been reported before. The patients were in a steady state at the time of the study (ie, no crisis, acute illness, or blood transfusion within the preceding 6 weeks). None of the patients was receiving chronic transfusion therapy. The study was approved by the appropriate Human 
Laboratory Tests
Blood was collected from each individual in the study by venipuncture into EDTA tubes. A complete blood count was done with an electronic cell counter. The Hb genotype was confirmed and the HbF concentration determined by cation exchange high-performance liquid chromatography. Other laboratory parameters (eg, serum bilirubin and lactate dehydrogenase) were obtained by standard methods. These tests were done within a month of the transcranial Doppler screening.
Transcranial Doppler Imaging
Transcranial Doppler imaging was performed in Kuwait and Oman by the same experienced vascular sonographer. In the former, he used Vivid 3 equipment (GE Healthcare, Milwaukee, WI), whereas in Oman and Al Ain (done by a radiologist), it was a portable LOGIQ e laptop system (GE Healthcare), both with a 1-3-MHz phased array transducer with color and power Doppler capabilities. In Iraq, it was done by a radiologist using a nonimaging technique (I17; Atys Medical, Soucieu en Jarrest, France). The procedure in all study participants was performed with a transtemporal or suboccipital approach. TAMMV, peak systolic velocity, end-diastolic velocity, pulsatility index, and resistive index were obtained in both the right and left terminal ICA, MCA, ACA, and posterior cerebral artery (PCA), vertebral artery (distal part), and basilar artery (mid part). Each artery was scanned from its bifurcation, along its course, and the highest velocity was recorded. No angle correction was used. Only TAMMV values were analyzed in this study because it is the index of interest in predicting stroke risk. The other indices are, however, being analyzed and may be reported separately. A TAMMV of less than 170 cm/s was considered normal; 170 to 200 cm/s was considered conditional; and greater than 200 cm/s was considered abnormal.
Statistical Analyses
Data are presented as mean 6 SD and were analyzed with SPSS version 23 software for Windows (IBM Corporation, Armonk, NY). The v 2 test was used to test the significance of differences in proportions, and Pearson correlation coefficients were computed between different parameters. The Student t test or analysis of variance was used to test for statistical significance between different means in the various subgroups, as appropriate, and P < .05 was taken as significant. A multiple regression Table 3 shows that patients with sickle D Hb had significantly higher Hb and hematocrit levels (P < .05); otherwise the hematologic parameters were similar. The Hb genotypes also did not show any consistent TAMMV patterns. Patients with sickle D genotype had a significantly higher mean value in the right ICA (P < .001), whereas sickle cell anemia had the highest levels in the right MCA (P 5 .008) and left ICA (P < .001). Patients with sickle cell b 0-thalassemia had a significantly higher mean value in the right PCA (P 5 .008), as shown in Table 3 .
The use of hydroxyurea was documented only among the Iraqi cohort, in whom 51 (21.5%) had been taking the drug for varying lengths of time. Interestingly, the HbF levels were not significantly different, but the hemoglobin and hematocrit levels were significantly higher and the reticulocyte count significantly lower in those taking hydroxyurea compared to those not taking the drug (Table 4) . Although the total white blood cell and absolute neutrophil counts were lower in the former, the differences were not significant. The patients taking hydroxyurea had significantly lower TAMMV values in both left and right MCA and left PCA (Table 4) . 
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Although none of the patients studied was receiving chronic transfusion therapy, 189 (79.8%) of the Iraqi cohort had received multiple transfusions at various times in the past but not within 6 weeks before the transcranial Doppler studies. The indications for transfusion were mostly hemolytic or acute splenic sequestration crises. When hematologic parameters were compared in this group against those who had never been transfused, Hb and HbF levels were significantly lower in the former, whereas the reticulocyte count was significantly lower compared to the latter group ( Table 4 ). The TAMMV values were significantly higher in the left and right MCA and PCA and right PCA among the transfused group (Table 4) .
When Pearson correlations were computed between age and laboratory parameters with the TAMMV in each of the arteries, Hb had a significant (P < . 
Discussion
The hallmark of SCD is its phenotypic heterogeneity, and nowhere is there as much diversity of the disease than in the Arabian Peninsula. All of the different b S haplotypes are encountered with varying levels of HbF. The predominant haplotype in Kuwait and Iraq is AI, whereas in addition to this, BEN and BAN haplotypes are also seen in the Omani and Emirati patients. Haplotyping was not part of the design of this study, but judging from the HbF levels, most of the patients in the 3 groups probably had the AI haplotype, which is associated with elevated levels. Only 13.1%, 21.1%, 16.2%, and 26% of patients from Iraq, Oman, Kuwait, and United Arab Emirates, respectively, had HbF levels of less than 10%.
Because of the dire morbidity and mortality associated with stroke in SCD, every effort is made to identify patients at risk, in whom chronic transfusion therapy is indicated for primary or secondary prevention. Stroke is, however, relatively uncommon among Peninsular Arab patients, and the preventive factors have not been clearly identified, but it is assumed that the high HbF level in most of the patients is protective, especially in childhood. 27, 28 The same observation has been made among Iranian patients with SCD. 19 A coexistent a-thalassemia trait, which is quite prevalent in the region, is another potential protective factor. 29, 30 Among the patients in this study, 1 each from Oman and Kuwait and 3 from Basra had a history of stroke. This finding was consistent with the reported figures of approximately 1.0% for childhood stroke among patients with SCD and the AI haplotype. 23, 27 A previous study, from Oman, which included adult patients, reported stroke prevalence of 20% among its patients but did not indicate how many had the AI haplotype. 20 The earlier study from Kuwait that documented transcranial Doppler findings in pediatric patients with SCD and the predominant AI haplotype did not report any patient with abnormal or conditional velocities in all of the arteries of the circle of Willis 21 that were interrogated. We were not certain whether this finding was a reflection of the rarity of cerebral vasculopathy or whether there is, indeed, a regional or ethnic variation. That possibility was the justification for this multinational, multicenter report. The results have generally confirmed our previous findings. Indeed, there were no abnormal or conditional values in all of the patients studied except in Iraq, where less than 5% had conditional values in the MCA.
Transcranial Doppler ultrasound has been the reference standard for identifying patients with SCD at risk for stroke since Adams 31 found that a cutoff velocity of 200 cm/s was predictive of ischemic stroke. However, transcranial Doppler ultrasound is operator dependent. For this reason, the procedure was performed in Kuwait and Oman by the same experienced vascular sonographer and by radiologists in the other centers. The equipment used in Kuwait and Oman was an imaging system, whereas in Iraq, it was a nonimaging system. Both give valid and reproducible results. However, imaging equipment produces lower velocity measurements than nonimaging equipment. 32, 33 This factor may partially explain why Iraqi patients had higher velocities than the other patients in this study.
The TAMMV values were similar in all of the cerebral arteries in the 4 cohorts studied, with the values in the MCA being the highest. It is remarkable, however, that despite the difference in equipment and personnel, there was no patient with a TAMMV in the abnormal range. The patient's sex and Hb genotype did not influence the TAMMV in a consistent pattern. However, as reported previously, 34 we also found that age, the Hb level, and the reticulocyte count showed significant correlations with the TAMMV. Although stenosis within an artery is probably the most substantial cause of increased velocity, the increased relative cardiac output in young children and in anemia could also affect the results.
Local experience in the region shows that about one-third of patients are taking hydroxyurea, which has been reported to lower TAMMV values in patients with SCD. [35] [36] [37] Hydroxyurea therapy was documented only among the Iraqi cohort and showed significant lowering of the TAMMV in both the MCAs and PCAs, although the reverse was true in the ICAs. On the other hand, episodic transfusion was not associated with a lowering of the TAMMV, but on the contrary, the values were significantly higher in those who had ever been transfused (but not within 6 weeks of the study). This finding would indicate that this group represented the more severely affected phenotypically.
Although this study has confirmed the rarity of an abnormal TAMMV among Peninsular Arabs with SCD, and may reflect the lack of substantial cerebral vasculopathy in childhood, it has several limitations. The patients were diverse in their Hb genotypes and b S haplotypes, and there could have been operator error, especially since both imaging and non-imaging transcranial Doppler equipment were used. The next study should, therefore, include even more well-characterized patients with a determination of the b S haplotypes, hydroxyurea therapy, and b-globin genotypes. The transcranial Doppler equipment (preferably with imaging capabilities) should be uniform, and the operators should be certified with regular monitoring to ensure consistency in interpretation.
